These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36348637)

  • 1. COVID-19 is not associated with worse long-term inflammatory bowel disease outcomes: a multicenter case-control study.
    Hong SJ; Bhattacharya S; Aboubakr A; Nadkarni D; Lech D; Ungaro RC; Agrawal M; Hirten RP; Greywoode R; Mone A; Chang S; Hudesman DP; Ullman T; Sultan K; Lukin DJ; Colombel JF; Axelrad JE
    Therap Adv Gastroenterol; 2022; 15():17562848221132363. PubMed ID: 36348637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 outcomes in patients with inflammatory bowel diseases in Latin America: Results from SECURE-IBD registry.
    Queiroz NSF; Martins CA; Quaresma AB; Hino AAF; Steinwurz F; Ungaro RC; Kotze PG
    J Gastroenterol Hepatol; 2021 Nov; 36(11):3033-3040. PubMed ID: 34151470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID.
    Weaver KN; Zhang X; Dai X; Watkins R; Adler J; Dubinsky MC; Kastl A; Bousvaros A; Strople JA; Cross RK; Higgins PDR; Ungaro RC; Bewtra M; Bellaguarda E; Farraye FA; Boccieri ME; Firestine A; Kappelman MD; Long MD
    Inflamm Bowel Dis; 2022 Oct; 28(10):1497-1505. PubMed ID: 34871388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Risk of Myocarditis in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study in Sweden.
    Sun J; Yao J; Olén O; Halfvarson J; Bergman D; Ebrahimi F; Roelstraete B; Rosengren A; Sundström J; Ludvigsson JF
    Am J Gastroenterol; 2024 Sep; 119(9):1866-1874. PubMed ID: 38315442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease.
    Parekh R; Zhang X; Ungaro RC; Brenner EJ; Agrawal M; Colombel JF; Kappelman MD
    Dig Dis Sci; 2022 Apr; 67(4):1271-1277. PubMed ID: 34181165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 and Outcomes in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
    Tripathi K; Godoy Brewer G; Thu Nguyen M; Singh Y; Saleh Ismail M; Sauk JS; Parian AM; Limketkai BN
    Inflamm Bowel Dis; 2022 Aug; 28(8):1265-1279. PubMed ID: 34718595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Bariatric Surgery on the Long-term Disease Course of Inflammatory Bowel Disease.
    Braga Neto MB; Gregory MH; Ramos GP; Bazerbachi F; Bruining DH; Abu Dayyeh BK; Kushnir VM; Raffals LE; Ciorba MA; Loftus EV; Deepak P
    Inflamm Bowel Dis; 2020 Jun; 26(7):1089-1097. PubMed ID: 31613968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Children and Expectant Mothers With Inflammatory Bowel Disease.
    Benchimol EI; Carroll MW; Geist R; Griffiths AM; Huang JG; Mack DR; Bernstein CN; Bitton A; Jones JL; Kaplan GG; Kuenzig ME; Lee K; Mukhtar MS; Murthy SK; Tandon P; Targownik LE; Windsor JW; Seow CH
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S27-S33. PubMed ID: 34755036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control study.
    Amiot A; Bourrier A; Gornet JM; Dewit O; Nancey S; Altwegg R; Abitbol V; Laharie D; Reenaers C; Gagnière C; Buisson A; Nachury M; Viennot S; Vuitton L; Stefanescu C; Marteau P; Bouguen G; Seksik P;
    Infect Prev Pract; 2023 Mar; 5(1):100267. PubMed ID: 36601289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe COVID-19 in inflammatory bowel disease patients in a population-based setting.
    Creemers RH; Rezazadeh Ardabili A; Jonkers DM; Leers MPG; Romberg-Camps MJ; Pierik MJ; van Bodegraven AA
    PLoS One; 2021; 16(10):e0258271. PubMed ID: 34610041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of Severe COVID-19 Outcomes and Immunization Rates in Apulian Individuals with Inflammatory Bowel Disease: A Retrospective Cohort Study.
    Bianchi FP; Contaldo A; Polignano MG; Pisani A
    Vaccines (Basel); 2024 Aug; 12(8):. PubMed ID: 39204007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study.
    Biancone L; Armuzzi A; Scribano ML; Castiglione F; D'Incà R; Orlando A; Papi C; Daperno M; Vecchi M; Riegler G; Fries W; Alvisi P; Meucci G; Mocciaro F; Rogai F; Festa S; Guidi L; Testa A; Spina L; Renna S; Viola A; Patturelli M; Di Mitri R; Frankovic I; Calabrese E; Petruzziello C; De Cristofaro E; Sena G; Ruffa A; Neri B; Rossi A
    Inflamm Bowel Dis; 2020 Feb; 26(3):450-459. PubMed ID: 31498388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta-analysis.
    Singh AK; Jena A; Kumar-M P; Sharma V; Sebastian S
    United European Gastroenterol J; 2021 Mar; 9(2):159-176. PubMed ID: 33210980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Vedolizumab on COVID-19 Outcomes Among Adult IBD Patients in the SECURE-IBD Registry.
    Agrawal M; Zhang X; Brenner EJ; Ungaro RC; Kappelman MD; Colombel JF
    J Crohns Colitis; 2021 Nov; 15(11):1877-1884. PubMed ID: 33884425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 2023 Impact of Inflammatory Bowel Disease in Canada: COVID-19 and IBD.
    Kaplan GG; Kuenzig ME; Windsor JW; Bernstein CN; Bitton A; Coward S; Jones JL; Lee K; Murthy SK; Targownik LE; Peña-Sánchez JN; Ghandeharian S; Rohatinsky N; Weinstein J; Jones May T; Browne M; Jannati N; Tabatabavakili S; Im JHB; Meka S; Vukovic S; Davis T; Goddard Q; Gorospe J; Stocks T; Caplan L; Kanaan N; Stuart D; Ramsay T; Robinson KJ; Charron-Bishop D; Benchimol EI
    J Can Assoc Gastroenterol; 2023 Sep; 6(Suppl 2):S76-S82. PubMed ID: 37674494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safe use of inflammatory bowel disease therapies during the COVID-19 pandemic.
    Kamath C; Brenner EJ
    Curr Res Pharmacol Drug Discov; 2022; 3():100101. PubMed ID: 35496814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD.
    Bernstein CN; Singh H; Murthy SK; Nguyen GC; Benchimol EI; Bitton A; Kuenzig ME; Huang JG; Jones JL; Lee K; Targownik LE; Windsor JW; Mukhtar MS; Tandon P; Kaplan GG
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S34-S39. PubMed ID: 34755037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-Term COVID-19 Pandemic-Related Endoscopy Delays Did Not Translate to Deleterious Outcomes for Patients With Inflammatory Bowel Disease: A Retrospective Cohort Study.
    Chambers J; Malhi G; Mikail M; Khanna R; Wilson A
    J Can Assoc Gastroenterol; 2022 Dec; 5(6):251-255. PubMed ID: 36467597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.